LXRX
Price
$0.71
Change
-$0.01 (-1.39%)
Updated
Dec 20, 04:59 PM (EDT)
81 days until earnings call
VIR
Price
$7.35
Change
-$0.02 (-0.27%)
Updated
Dec 20, 04:59 PM (EDT)
61 days until earnings call
Ad is loading...

LXRX vs VIR

Header iconLXRX vs VIR Comparison
Open Charts LXRX vs VIRBanner chart's image
Lexicon Pharmaceuticals
Price$0.71
Change-$0.01 (-1.39%)
Volume$43.28K
CapitalizationN/A
Vir Biotechnology
Price$7.35
Change-$0.02 (-0.27%)
Volume$13.34K
CapitalizationN/A
LXRX vs VIR Comparison Chart
Loading...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXRX vs. VIR commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXRX is a Hold and VIR is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (LXRX: $0.71 vs. VIR: $7.34)
Brand notoriety: LXRX and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXRX: 146% vs. VIR: 235%
Market capitalization -- LXRX: $258.36M vs. VIR: $1.01B
LXRX [@Biotechnology] is valued at $258.36M. VIR’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXRX’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • LXRX’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than LXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 3 bullish TA indicator(s).

  • LXRX’s TA Score: 5 bullish, 2 bearish.
  • VIR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, LXRX is a better buy in the short-term than VIR.

Price Growth

LXRX (@Biotechnology) experienced а -11.80% price change this week, while VIR (@Biotechnology) price change was -1.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

LXRX is expected to report earnings on Mar 12, 2025.

VIR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.01B) has a higher market cap than LXRX($258M). VIR YTD gains are higher at: -27.038 vs. LXRX (-53.288). LXRX has higher annual earnings (EBITDA): -198.7M vs. VIR (-562.68M). VIR has more cash in the bank: 914M vs. LXRX (258M). LXRX has less debt than VIR: LXRX (101M) vs VIR (113M). VIR has higher revenues than LXRX: VIR (62M) vs LXRX (5.23M).
LXRXVIRLXRX / VIR
Capitalization258M1.01B26%
EBITDA-198.7M-562.68M35%
Gain YTD-53.288-27.038197%
P/E RatioN/AN/A-
Revenue5.23M62M8%
Total Cash258M914M28%
Total Debt101M113M89%
FUNDAMENTALS RATINGS
LXRX: Fundamental Ratings
LXRX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXRXVIR
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BKRDX7.850.13
+1.68%
iShares Developed Real Estate Idx K
ISTIX70.44N/A
N/A
Delaware Ivy Science and Technology I
GMVRX16.14N/A
N/A
Goldman Sachs Small/Mid Cap Value R
LHCOX19.54N/A
N/A
Lord Abbett Health Care F3
PAXLX12.81-2.06
-13.87%
Impax Large Cap Fund Individual Investor

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with EPIX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then EPIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
-1.23%
EPIX - LXRX
44%
Loosely correlated
N/A
FRTX - LXRX
41%
Loosely correlated
-0.34%
NTLA - LXRX
37%
Loosely correlated
+1.08%
BEAM - LXRX
37%
Loosely correlated
+8.16%
SPRO - LXRX
37%
Loosely correlated
-3.84%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with ADPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-0.41%
ADPT - VIR
48%
Loosely correlated
+6.67%
AVIR - VIR
48%
Loosely correlated
+2.56%
AXON - VIR
47%
Loosely correlated
+2.59%
CRSP - VIR
46%
Loosely correlated
+0.83%
TECH - VIR
44%
Loosely correlated
+2.54%
More